BI

BVF Inc Portfolio holdings

AUM $3.14B
1-Year Est. Return 249.53%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+249.53%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.14B
AUM Growth
+$168M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
45
New
Increased
Reduced
Closed

Top Buys

1
+$62M
2
+$56.9M
3
+$43.2M
4
STRO icon
Sutro Biopharma
STRO
+$22.6M
5
AVR
Anteris Technologies
AVR
+$17.2M

Top Sells

1
+$68.5M
2
+$62.1M
3
+$50.5M
4
RPTX
Repare Therapeutics
RPTX
+$26.9M
5
FDMT icon
4D Molecular Therapeutics
FDMT
+$15.2M

Sector Composition

1 Healthcare 99.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STRO icon
26
Sutro Biopharma
STRO
$484M
$31.2M 0.99%
+1,251,788
FHTX icon
27
Foghorn Therapeutics
FHTX
$251M
$27.9M 0.89%
5,842,000
+540,000
FDMT icon
28
4D Molecular Therapeutics
FDMT
$518M
$26.8M 0.85%
2,879,289
-1,750,000
IVVD icon
29
Invivyd
IVVD
$336M
$25.4M 0.81%
19,525,000
AVTX icon
30
Avalo Therapeutics
AVTX
$838M
$24.4M 0.78%
1,632,845
+277,588
ELDN icon
31
Eledon Pharmaceuticals
ELDN
$294M
$19.4M 0.62%
6,293,282
AVR
32
Anteris Technologies
AVR
$839M
$16.6M 0.53%
+3,000,000
XFOR icon
33
X4 Pharmaceuticals
XFOR
$407M
$9.23M 0.29%
2,233,742
IMUX icon
34
Immunic
IMUX
$204M
$8.49M 0.27%
765,297
OKUR
35
OnKure Therapeutics
OKUR
$170M
$8.19M 0.26%
+1,978,972
TCRX icon
36
TScan Therapeutics
TCRX
$70.6M
$5.62M 0.18%
5,564,290
+338,216
IMA
37
ImageneBio Inc
IMA
$66.3M
$5.55M 0.18%
1,110,002
+307,900
TENX icon
38
Tenax Therapeutics
TENX
$315M
$5.43M 0.17%
339,549
MOLN
39
Molecular Partners
MOLN
$158M
$5.36M 0.17%
1,353,968
IVA
40
Inventiva
IVA
$1.03B
$3.81M 0.12%
686,040
ENGNW icon
41
enGene Therapeutics Warrants
ENGNW
$3.02M
$2.49M 0.08%
945,402
ABVX
42
Abivax
ABVX
$10.6B
– –
-508,031
AXSM icon
43
Axsome Therapeutics
AXSM
$12.1B
– –
-45,757
PEPG icon
44
PepGen
PEPG
$104M
– –
-1,915,000
RPTX
45
DELISTED
Repare Therapeutics
RPTX
– –
-10,333,600
1
2